Novartis announces the appointment of the
Gilbert Ghostine, CEO of the Swiss multi-national fragrances business Firmenich appointed Chairman-Designate of the future Sandoz BoardMr Ghostine to begin......
Sandoz Biologics License Application for proposed
Submission supported by comprehensive analytical and clinical data package Denosumab indicated for treating variety of conditions including......
Patients with hidradenitis suppurativa experienced
In two of the largest Phase III trials conducted in hidradenitis suppurativa (HS), Cosentyx® (secukinumab) treatment response rates continued to improve......
Sandoz receives positive CHMP opinion for citrate-free high
Sandoz is seeking approval of high concentration formulation (HCF) adalimumab for use in all indications of reference medicine Upon approval, HCF......